Getting your Trinity Audio player ready...

Dyadic International Inc. (NASDAQ: DYAI), a biotechnology company specializing in large-scale protein manufacturing for vaccines, therapeutics, and non-pharmaceutical applications like biofuels and next-generation foods, (read entire press release) reached a new 52-week high of $2.42 on Thursday, May 30, 2024. This achievement marks a significant 103% increase from its 52-week low of $1.19. The stock’s 50-day moving average stands at $1.6631, while the 200-day moving average is $1.6521, culminating in a “Golden Cross” on May 30, 2024. Furthermore, the stock demonstrated a “Jack in the Box” pattern with a Bullish Swing Set-Up on Friday, May 31, 2024. Read the full press release for more details.

As the bird flu outbreak looms, with a third person now infected, the U.S. government has initiated discussions with Moderna (NASDAQ: MRNA) regarding an avian flu vaccine. Other companies, including Pfizer (NYSE: PFE), Novavax (NASDAQ: NVAX), BioNTech (NASDAQ: BNTX), and Dyadic International Inc. (NASDAQ: DYAI), are also potential collaborators. For Dyadic’s latest developments in more detail, read more now! 

Dyadic International Inc. (NASDAQ: DYAI) was recently featured with other MEME stocks trending now: GameStop (NYSE: GME). AMC Entertainment (NYSE: AMC)Novavax Inc. (NASDAQ: NVAX), among others, Read more.

Dyadic International’s COO, Joe Hazelton, recently discussed the bird flu threat, the company’s expansion into next-generation foods, and the “Food vs Fuel” debate on “The Street Reports Podcast,” Listen Now! Furthermore, the company said that the management will attend key industry events in June 2024.  These events include BIO 2024 San Diego, CA, from June 3–6, with a presentation on June 5 at 11:00 AM PT; Future Food Tech-Alt Proteins at the Chicago, IL, from June 17–18; and the 2024 NIIMBL National Meeting in, Washington, DC, from June 25–27.